This inventor holds 5 USPTO granted patents and 3 published patent applications and 5 EPO patents. Top assignees: Bristol-Myers Squibb Compnay, Merck Sharp + Dohme Corp.. Active years: 2013-2026.
Location History:
- Monmouth Junction, NJ (US) (2013)
- Somerset, NJ (US) (2015 - 2016)
- Flemington, NJ (US) (2022)
Company Filing History:
3 out of 3,736 
3 out of 2,405 
Years Active: 2013-2026
Title: Neil A Strotman: Innovator in Pharmaceutical Chemistry
Introduction
Neil A Strotman is a notable inventor based in Flemington, NJ (US), recognized for his contributions to pharmaceutical chemistry. He holds a total of four patents, showcasing his innovative approach to drug development and synthesis.
Latest Patents
Strotman's latest patents include a process for preparing indole carboxamide compounds. This process involves several steps, including the preparation of a compound of Formula (III) and its conversion to a compound of Formula (V). The final reaction yields (S)-4-(3-(but-2-ynamido)piperidin-1-yl)-5-fluoro-2,3-dimethyl-1H-indole-7-carboxamide. Another significant patent is for the preparation of N,N-dicyclopropyl-4-(1,5-dimethyl-1H-pyrazol-3-ylamino)-6-ethyl-1-methyl-1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridine-7-carboxamide. This compound is currently undergoing clinical trials for the treatment of myeloproliferative disorders, including polycythaemia vera, thrombocythaemia, and primary myelofibrosis.
Career Highlights
Throughout his career, Strotman has worked with prominent companies in the pharmaceutical industry, including Merck Sharp & Dohme Corporation and Bristol-Myers Squibb Company. His work has significantly impacted the development of new therapeutic agents.
Collaborations
Strotman has collaborated with esteemed colleagues such as Carl A Baxter and Edward Cleator, contributing to advancements in pharmaceutical research and development.
Conclusion
Neil A Strotman is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in drug development. His innovative patents and collaborations highlight his commitment to improving healthcare through scientific research.